Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design.
Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design.
复制标题
DOI:
10.1038/tpj.2011.18
复制
发表时间:
2012-10
期刊:
影响因子:
--
通讯作者:
Gage BF
中科院分区:
文献类型:
--
作者:
Do EJ;Lenzini P;Eby CS;Bass AR;McMillin GA;Stevens SM;Woller SC;Pendleton RC;Anderson JL;Proctor P;Nunley RM;Davila-Roman V;Gage BF
The risk of venous thromboembolism (VTE) is higher after total hip or knee replacement surgery than after almost any other surgical procedure; warfarin sodium is commonly prescribed to reduce this peri-operative risk. Warfarin has a narrow therapeutic window with high inter-individual dose variability and can cause hemorrhage. The Genetics-InFormatics Trial (GIFT) of Warfarin to Prevent Deep Vein Thrombosis (DVT) is a 2×2 factorial-design, randomized controlled trial designed to compare the safety and effectiveness of warfarin-dosing strategies. GIFT will answer two questions: (1) Does pharmacogenetic (PGx) dosing reduce the rate of adverse events in orthopedic patients; and (2) Is a lower target International Normalized Ratio (INR) non-inferior to a higher target INR in orthopedic participants? The composite primary endpoint of the trial is symptomatic and asymptomatic VTE (identified on screening ultrasonography), major hemorrhage, INR ≥ 4, and death.
登录
查看更多内容
影响因子:
--
作者:
Douketis, JD;Foster, GA;Ginsberg, JS
通讯作者:
Ginsberg, JS
影响因子:
39.2
作者:
Eckman, Mark H.;Rosand, Jonathan;Gage, Brian F.
通讯作者:
Gage, Brian F.
影响因子:
158.5
作者:
Kearon, C;Ginsberg, JS;Gent, M
通讯作者:
Gent, M
影响因子:
158.5
作者:
Francis, CW;Berkowitz, SD;Colwell, CW
通讯作者:
Colwell, CW
影响因子:
2.9
作者:
Enyart, JJ;Jones, RJ
通讯作者:
Jones, RJ